Nextgen Biosciences is a biotechnology company dedicated to developing innovative therapeutics for autoimmune and fibrotic diseases, addressing high unmet medical needs and providing new hope for patients.

Our team of experts, with decades of experience in drug development, is committed to advancing breakthrough therapies. From AI-driven molecular modeling for candidate discovery to medicinal chemistry, bioevaluation, preclinical and clinical trials, and regulatory approvals, we integrate cutting-edge technology and expertise across all stages of drug development.

By expanding our pipeline to target diseases with significant unmet needs—such as alopecia areata, ulcerative colitis, idiopathic pulmonary fibrosis, and age-related macular degeneration—we aim to become a global leader in developing novel treatments for autoimmune and fibrotic diseases.